Cancer Samples
Cancer research plays an essential role in advancing medical science, offering insights into early diagnosis, treatment development, and understanding tumor biology. A key factor in this progress is the availability of high-quality biospecimens, which enable researchers to study cancer at the molecular level. Central BioHub’s extensive collection of over 20,500 cancer samples provides the necessary materials to support a broad range of oncology studies.
The biological samples include a variety of matrices like plasma, serum, urine, buffy coat, tissue FFPE, and PBMC, and they are tested for significant cancer markers such as Cancer-antigen 125 (CA 125), Cancer-antigen 15-3 (CA 15-3), Cancer-antigen 19-9 (CA 19-9), Carcinoembryonic antigen (CEA), and Cytokeratin-19 fragments (CYFRA 21-1). These biomarkers are widely used in cancer research to understand tumor behavior, develop diagnostic tools, and assess therapeutic options.
Our cancer biospecimens come with comprehensive clinical data, including detailed treatment history, enabling researchers to correlate sample characteristics with therapeutic response and clinical outcomes.
Comprehensive Cancer Sample Collection
Central BioHub offers a comprehensive range of cancer samples across various matrices, each supporting different oncological research needs. Plasma and serum samples are essential for liquid biopsy research and biomarker validation, enabling non-invasive monitoring of cancer progression and treatment response. Urine samples, often used in bladder cancer studies, also aid in screening for other malignancies, offering a convenient option for non-invasive diagnostics. Buffy coat and PBMC samples, rich in immune cells, are valuable for cancer immunology research, as scientists continue to explore how the immune system interacts with cancer. FFPE tissue samples can provide detailed histopathological data crucial for studies on tumor biology, molecular profiling, and gene expression analysis.
Cancer Biomarkers and Their Role in Research
Central BioHub's cancer samples are tested for several important biomarkers, which offer valuable insights into cancer detection, prognosis, and treatment strategies:
· Cancer-antigen 125 (CA 125): A biomarker commonly used for ovarian cancer detection, CA 125 helps identify early-stage tumors and monitor treatment effectiveness.
· Cancer-antigen 15-3 (CA 15-3): Primarily associated with breast cancer, CA 15-3 helps researchers measure tumor burden and track disease progression.
· Cancer-antigen 19-9 (CA 19-9): This marker is frequently elevated in gastrointestinal cancers, including pancreatic cancer, and is valuable for assessing the tumor's response to therapy.
· Carcinoembryonic antigen (CEA): CEA helps in the detection of several cancer types, including colorectal and lung cancers, and supports prognosis and post-treatment monitoring.
· Cytokeratin-19 fragment (CYFRA 21-1): Used particularly in non-small cell lung cancer research, CYFRA 21-1 is helpful in evaluating treatment outcomes and disease progression.
These biomarkers play an essential role in understanding the clinical behavior of cancer and are integral to developing strategies for early diagnosis and personalized treatment.
Central BioHub’s Cancer Samples
Central BioHub’s expansive inventory of cancer biospecimens spans various research categories, supporting diverse oncology studies. Our FFPE tissue samples can be used for both histological and molecular analysis. Our lung cancer samples can contribute to advancing diagnostics and treatments, as lung cancer remains a major focus in oncology research. Additionally, our collection of triple-negative breast cancer samples offers researchers the opportunity to study this aggressive subtype, which presents unique challenges in terms of diagnosis and treatment, helping to drive progress in targeted therapies.
With our wide selection of cancer biospecimens, researchers are equipped to explore innovative solutions, improve cancer diagnostics, and develop targeted treatments. Central BioHub’s online marketplace provides a seamless connection between researchers and the biospecimens they need, backed by reliable customer support and efficient sample delivery.
Streamlined Access to Cancer Samples
At Central BioHub, we emphasize both the quality of our cancer biospecimens and the ease with which researchers can access them. Our online marketplace is designed to simplify the sample procurement process, allowing researchers to focus on their studies without administrative burdens:
· Efficient Order Management: Central BioHub’s platform integrates advanced search capabilities, making it easy for researchers to locate the exact cancer samples they need. Our refined search filters and sorting options enable quick access to specific biospecimens, helping researchers identify the right samples with precision.
· Competitive Pricing: We provide high-quality samples at competitive prices, ensuring researchers can make the most of their resources without compromising on sample quality.
· Fast Shipping: With shipping times ranging from 5 to 10 days, Central BioHub facilitates rapid order fulfilment, allowing researchers to move forward with their studies quickly.
· Detailed Histopathological Data: Samples come with detailed histopathological data, which is particularly useful for molecular studies and in-depth analysis.
· Advanced Excel Export Capabilities: Researchers can download advanced Excel reports of their search results, making it easier to manage and analyze data efficiently. This feature significantly reduces administrative workload, helping researchers transition smoothly from searching to studying.
Find cancer samples for your research on our website –
https://centralbiohub.de/biospecimens/cancer-samples
Register now on our website for free and find the research specimen that best fits your needs by clicking on Clinical Diagnosis, ICD-10-CM Codes, Matrix, and Laboratory Parameters.
Central BioHub - Order biospecimens online.